Type 2 diabetes sits in a chair

Thomas Solomon; J P Thyfault

doi:10.1111/dom.12105

Type 2 diabetes sits in a chair

Thomas Solomon, J P Thyfault

Inflammation, Metabolism and Oxidation

19 Citationer (Scopus)

Abstract

The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism Online
Vol/bind	15
Udgave nummer	11
Sider (fra-til)	987-992
Antal sider	6
ISSN	1463-1326
DOI	https://doi.org/10.1111/dom.12105
Status	Udgivet - nov. 2013

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1111/dom.12105

Citationsformater

@article{f543fbb1427644759627bd0e317ac5cf,

title = "Type 2 diabetes sits in a chair",

abstract = "The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?",

author = "Thomas Solomon and Thyfault, {J P}",

note = "{\textcopyright} 2013 Blackwell Publishing Ltd.",

year = "2013",

month = nov,

doi = "10.1111/dom.12105",

language = "English",

volume = "15",

pages = "987--992",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Type 2 diabetes sits in a chair

AU - Solomon, Thomas

AU - Thyfault, J P

PY - 2013/11

Y1 - 2013/11

N2 - The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?

AB - The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?

U2 - 10.1111/dom.12105

DO - 10.1111/dom.12105

M3 - Journal article

C2 - 23551885

SN - 1462-8902

VL - 15

SP - 987

EP - 992

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 11

ER -

Type 2 diabetes sits in a chair

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater